Novamedica Signs Distribution Agreement With Aptalis Pharmaceutical Technologies To Develop And Commercialize Gastrointestinal Pharmaceutical Products In Russia

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MOSCOW--(BUSINESS WIRE)--NovaMedica LLC, a Russian pharmaceutical company, has signed a partnership agreement with Aptalis Pharma, a leading specialty pharmaceutical company, providing innovative, effective therapies for unmet medical needs, to develop and commercialize a portfolio of three of Aptalis Pharma’s novel gastrointestinal pharmaceutical products in Russia.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC